Efficacy and Safety of the N0750 Compared to Monotherapies in the Treatment of Painful Diabetic Peripheral Neuropathy

NCT06715462 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Strategic change in development priorities

Conditions

Painful Diabetic Peripheral Neuropathy (PDPN)

Interventions

DRUG: N0750
DRUG: Cymbalta®
DRUG: Lyrica®

Sponsor

Eurofarma Laboratorios S.A.